Profound Medical Corp.

9.11 USD
+0.20 (+2.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Profound Medical Corp. stock is up 6.62% since 30 days ago. The next earnings date is Aug 7, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 50% of the previous 8 June’s closed higher than May.

About Profound Medical Corp.

Profound Medical Corp. develops magnetic resonance guided ablation procedures for treatment of prostate disease, uterine fibroids, and palliative pain treatment. Its lead product TULSA-PRO system used for magnetic resonance imaging scanner in hospitals and treatment facilities.